Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Propranolol Hydrochloride Extended-Release Capsules USP
Medication labelWhy this: Advisory · dailymed-prescription
Propranolol hydrochloride extended-release capsules USP are indicated in the management of hypertension. They may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. Propranolol hydrochloride extended-release capsules USP are not indicated in the management of hypertensive emergencies. Propranolol hydrochloride extended-release capsules USP are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. Propranolol hydrochloride extended-release capsules USP are indicated for the prophylaxis of common migraine headache. The efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use. Propranolol hydrochloride extended-release capsules USP improve NYHA functional class in symptomatic patients with hypertrophic subaortic stenosis.
- generic_name
- propranolol hydrochloride
- product_names
- propranolol hydrochloride
- ndc
- 62559-530, 62559-530-01, 62559-531, 62559-531-01, 62559-532, 62559-532-01, 62559-533, 62559-533-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en